Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients

Metabolism: Clinical and Experimental

Volumn 63, Issue 4, 2014, Pages 520-531

  Crujeiras, Ana B ^a,b,d   Zulet, M Angeles ^c,d   Lopez Legarrea, Patricia ^c,d   De La Iglesia, Rocío ^c,d   Pardo, María ^a,d   Carreira, Marcos C ^a,d   Martínez, J Alfredo ^c,d   Casanueva, Felipe F ^a,d  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

FNDC5; Hypocaloric diet; Insulin sensitivity; Weight regain

Indexed keywords

ADIPONECTIN; GHRELIN; HORMONE; INSULIN; IRISIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLUCOSE HOMEOSTASIS; HEALTH PROMOTION; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRISIN BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

FNDC5; HYPOCALORIC DIET; INSULIN SENSITIVITY; WEIGHT REGAIN;

ADIPONECTIN; ADULT; FEMALE; FIBRONECTINS; GHRELIN; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; OBESITY; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84896495884     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.12.007     Document Type: Article

References (60)

1. G.A. Bray Why do we need drugs to treat the patient with obesity? Obesity (Silver Spring) 21 5 2013 893 899
2. R.R. Wing, P. Bolin, and F.L. Brancati et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 369 2 2013 145 154
3. P.S. Maclean, A. Bergouignan, and M.A. Cornier et al. Biology's response to dieting: The impetus for weight regain Am J Physiol Regul Integr Comp Physiol 301 3 2011 R581 R600
4. D.P. Beavers, K.M. Beavers, and M.F. Lyles et al. Cardiometabolic risk after weight loss and subsequent weight regain in overweight and obese postmenopausal women J Gerontol A Biol Sci Med Sci 68 6 2012 691 698
5. G. Calori, G. Lattuada, and L. Piemonti et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: The Cremona Study Diabetes Care 34 1 2011 210 215
6. G.M. Reaven Insulin resistance: The link between obesity and cardiovascular disease Endocrinol Metab Clin North Am 37 3 2008 581 601 [vii-viii]
7. B. Arcidiacono, S. Iiritano, and A. Nocera et al. Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms Exp Diabetes Res 2012 2012 789174
8. V. Catalan, J. Gomez-Ambrosi, and A. Rodriguez et al. Adipokines in the treatment of diabetes mellitus and obesity Expert Opin Pharmacother 10 2 2009 239 254
9. P. Bostrom, J. Wu, and M.P. Jedrychowski et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 7382 2012 463 468
10. M.A. Schumacher, N. Chinnam, and T. Ohashi et al. Structure of irisin reveals a novel intersubunit beta-sheet fibronectin (FNIII) dimer; implications for receptor activation J Biol Chem 2013 10.1074/jbc.M113.516641
11. S.A. Polyzos, J. Kountouras, and K. Shields et al. Irisin: A renaissance in metabolism? Metabolism 62 8 2013 1037 1044
12. S. Raschke, M. Elsen, and H. Gassenhuber et al. Evidence against a beneficial effect of irisin in humans PLoS One 8 9 2013 e73680
13. A. Besse-Patin, E. Montastier, and C. Vinel et al. Effect of endurance training on skeletal muscle myokine expression in obese men: Identification of apelin as a novel myokine Int J Obes (Lond) 2013 10.1038/ijo.2013.158
14. J.N. Fain, J.M. Company, and F.W. Booth et al. Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs Metabolism 62 10 2013 1503 1511
15. R.R. Kraemer, P. Shockett, and N.D. Webb et al. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women Horm Metab Res 2013 10.1055/s-0033-1355381
16. C. Moraes, V.O. Leal, and S.M. Marinho et al. Resistance exercise training does not affect plasma irisin levels of hemodialysis patients Horm Metab Res 45 12 2013 900 904
17. S. Pekkala, P. Wiklund, and J.J. Hulmi et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol 291 Pt21 2013 5393 5400
18. J.A.B.K. Timmons, P.K. Davidsen, and P.J. Atherton Is irisin a human exercise gene? Nature 488 7413 2012 E9 E10
19. M.T. Vamvini, K.N. Aronis, and G. Panagiotou et al. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans Eur J Endocrinol 169 6 2013 829 834
20. A. Roca-Rivada, C. Castelao, and L.L. Senin et al. FNDC5/irisin is not only a myokine but also an adipokine PLoS One 8 4 2013 e60563
21. S.L. Dun, R.M. Lyu, and Y.H. Chen et al. Irisin-immunoreactivity in neural and non-neural cells of the rodent Neuroscience 240 2013 155 162
22. M.S. Hashemi, K. Ghaedi, and A. Salamian et al. Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells Neuroscience 231 2012 296 304
23. H.S. Moon, F. Dincer, and C.S. Mantzoros Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines Metabolism 62 8 2013 1131 1136
24. H.S. Moon, and C.S. Mantzoros Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines Metabolism 2013 10.1016/j.metabol.2013.10.005 [pii: S0026-0495(13)00337-5s]
25. S. Aydin, T. Kuloglu, and S. Aydin Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus Peptides 47C 2013 66 70
26. Y.K. Choi, M.K. Kim, and K.H. Bae et al. Serum irisin levels in new-onset type 2 diabetes Diabetes Res Clin Pract 100 1 2013 96 101
27. J.J. Liu, M.D. Wong, and W.C. Toy et al. Lower circulating irisin is associated with type 2 diabetes mellitus J Diabetes Complications 27 4 2013 365 369
28. J.M. Moreno-Navarrete, F. Ortega, and M. Serrano et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance J Clin Endocrinol Metab 98 4 2013 E769-678
29. H.J. Zhang, X.F. Zhang, and Z.M. Ma et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults J Hepatol 59 3 2013 557 562
30. M.S. Wen, C.Y. Wang, and S.L. Lin et al. Decrease in irisin in patients with chronic kidney disease PLoS One 8 5 2013 e64025
31. S.H. Lecker, A. Zavin, and P. Cao et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure Circ Heart Fail 5 6 2012 812 818
32. A. Gratas-Delamarche, F. Derbre, and S. Vincent et al. Physical inactivity, insulin resistance, and the oxidative-inflammatory loop Free Radic Res 2013 10.3109/10715762.2013.847528
33. I. Gouni-Berthold, H.K. Berthold, and J.Y. Huh et al. Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo PLoS One 8 9 2013 e72858
34. S.A. Polyzos, J. Kountouras, and A.D. Anastasilakis et al. Irisin in patients with nonalcoholic fatty liver disease Metabolism 2013 10.1016/j.metabol.2013.09.013 [pii: S0026-0495(13)00297-7]
35. K.H. Park, L. Zaichenko, and P. Peter et al. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans Metabolism 2013 10.1016/j.metabol.2013.10.011
36. P. Lopez-Legarrea, R. de la Iglesia, and I. Abete et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: The RESMENA randomized controlled trial Nutr Metab (Lond) 10 1 2013 22
37. R. de la Iglesia, P. Lopez-Legarrea, and P. Celada et al. Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption Int J Mol Sci 14 4 2013 6903 6919
38. A.B. Crujeiras, D. Parra, and E. Goyenechea et al. Tachyphylaxis effects on postprandial oxidative stress and mitochondrial-related gene expression in overweight subjects after a period of energy restriction Eur J Nutr 48 6 2009 341 347
39. D.R. Matthews, J.P. Hosker, and A.S. Rudenski et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
40. J.L. Kuk, and C.I. Ardern Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32 12 2009 2297 2299
41. R. Mera, H. Thompson, and C. Prasad How to calculate sample size for an experiment: A case-based description Nutr Neurosci 1 1998 87 91
42. A.B. Crujeiras, E. Goyenechea, and I. Abete et al. Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels J Clin Endocrinol Metab 95 11 2010 5037 5044
43. M.A. Martinez-Gonzalez, C. Lopez-Fontana, and J.J. Varo et al. Validation of the Spanish version of the physical activity questionnaire used in the Nurses' Health Study and the Health Professionals' Follow-up Study Public Health Nutr 8 7 2005 920 927
44. A.B. Crujeiras, A. Diaz-Lagares, and I. Abete et al. Pre-treatment circulating leptin/ghrelin ratio as a non-invasive marker to identify patients likely to regain the lost weight after an energy restriction treatment J Endocrinol Invest 2013 10.1007/s40618-013-0004-2
45. M.H. Wong, C. Holst, and A. Astrup et al. Caloric restriction induces changes in insulin and body weight measurements that are inversely associated with subsequent weight regain PLoS One 7 8 2012 e42858
46. L.F. Lien, A.M. Haqq, and M. Arlotto et al. The STEDMAN project: Biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain Omics 13 1 2009 21 35
47. I. Padmalayam, and M. Suto Role of adiponectin in the metabolic syndrome: Current perspectives on its modulation as a treatment strategy Curr Pharm Des 19 32 2013 5755 5763
48. M. Amitani, A. Asakawa, and H. Amitani et al. The role of leptin in the control of insulin-glucose axis Front Neurosci 7 2013 51
49. Z.A. Knight, K.S. Hannan, and M.L. Greenberg et al. Hyperleptinemia is required for the development of leptin resistance PLoS One 5 6 2010 e11376
50. F. Villarroya Irisin, turning up the heat Cell Metab 15 3 2012 277 278
51. J.Y. Huh, G. Panagiotou, and V. Mougios et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 12 2012 1725 1738
52. A. Stengel, T. Hofmann, and M. Goebel-Stengel et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index Peptides 39C 2012 125 130
53. A.B. Crujeiras, M. Pardo, and A. Roca-Rivada et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women Am J Hum Biol 2013 10.1002/ajhb.22493
54. M.D. Roberts, D.S. Bayless, and J.M. Company et al. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats Metabolism 62 8 2013 1052 1056
55. A.G. Swick, S. Orena, and A. O'Connor Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass Metabolism 62 8 2013 1070 1073
56. H. Staiger, A. Bohm, and M. Scheler et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'Browning' factor irisin, determines insulin sensitivity PLoS One 8 4 2013 e61903
57. K.H. Park, L. Zaichenko, and M. Brinkoetter et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome J Clin Endocrinol Metab 2013 10.1210/jc.2013-2373
58. K. Hojlund, and P. Bostrom Irisin in obesity and type 2 diabetes J Diabetes Complications 27 4 2013 303 304
59. G. Mohammadzadeh, and N. Zarghami Serum leptin level is reduced in non-obese subjects with type 2 diabetes Int J Endocrinol Metab 11 1 2013 3 10
60. H.P. Erickson Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor? Adipocyte 2 4 2013 289 293